Abstract
MicroRNAs (miRNAs) are small regulatory RNAs that can regulate gene expression by binding to mRNA sequences and repressing target-gene expression post-transcriptionally, either by inhibiting translation or promoting RNA degradation. We have analysed expression of 328 known and 152 novel human miRNAs in 10 benign peripheral zone tissues and 16 prostate cancer tissues using microarrays and found widespread, but not universal, downregulation of miRNAs in clinically localized prostate cancer relative to benign peripheral zone tissue. These findings have been verified by real-time RT–PCR assays on select miRNAs, including miR-125b, miR-145 and let-7c. The downregulated miRNAs include several with proven target mRNAs whose proteins have been previously shown to be increased in prostate cancer by immunohistochemistry, including RAS, E2F3, BCL-2 and MCL-1. Using a bioinformatics approach, we have identified additional potential mRNA targets of one of the miRNAs, (miR-125b) that are upregulated in prostate cancer and confirmed increased expression of one of these targets, EIF4EBP1, in prostate cancer tissues. Our findings indicate that changes in miRNA expression may have an important role in the biology of human prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barberis MCP, Roz E, Biunno I . (2006). SEL1L expression in prostatic intraepithelial neoplasia and adenocarcinoma: an immunohistochemical study. Histopathology 48: 614–616.
Biunno I, Cattaneo M, Orlandi R, Canton C, Biagiotti L, Ferrero S et al. (2006). SEL1L: a multifaceted protein playing a role in tumor progression. J Cell Physiol 208: 23–38.
Eisen MB, Spellman PT, Brown PO, Botstein D . (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863–14868.
Gorgoni B, Gray NK . (2004). The roles of cytoplasmic poly(A)-binding proteins in regulating gene expression: a developmental perspective. Brief Funct Genomic Proteomic 3: 125–141.
Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ . (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140–D144.
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065–7070.
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635–647.
Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ et al. (2007). A microRNA signature of hypoxia. Mol Cell Biol 27: 1859–1867.
Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T . (2007). Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673–677.
Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K et al. (2004). Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 101: 811–816.
Liu C-G, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M et al. (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101: 9740–9744.
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834–838.
Marsit CJ, Eddy K, Kelsey KT . (2006). MicroRNA responses to cellular stress. Cancer Res 66: 10843–10848.
Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK et al. (2006). Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24.
Rojo F, Najera L, Lirola J, Jimenez J, Guzman M, Sabadell MD et al. (2007). 4E-binding protein 1: a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin Cancer Res 13: 81–89.
Saldanha AJ . (2004). Java Treeview: extensible visualization of microarray data. Bioinformatics 20: 3246–3248.
Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R et al. (2005). An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 11: 1461–1470.
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257–2261.
Voorhoeve PM, Agami R . (2006). Classifying microRNAs in cancer: the good, the bad and the ugly. Biochim Biophys Acta 1775: 274–282.
Wang JH, Weng JS, Cai Y, Penland R, Liu MY, Ittmann M . (2006). The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Prostate 66: 847–857.
Wu W, Sun M, Zou GM, Chen JJ . (2007). MicroRNA and cancer: current status and prospective. Int J Cancer 120: 953–960.
Acknowledgements
This work was supported by grants from the Department of Veterans Affairs Merit Review program (MI) and the National Cancer Institute to the Baylor prostate cancer SPORE program (P50CA058204) and by use of the facilities of the Michael E DeBakey Department of Veterans Affairs Medical Center.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Ozen, M., Creighton, C., Ozdemir, M. et al. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27, 1788–1793 (2008). https://doi.org/10.1038/sj.onc.1210809
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210809
Keywords
This article is cited by
-
Loss of miR-936 leads to acquisition of androgen-independent metastatic phenotype in prostate cancer
Scientific Reports (2022)
-
Association between single-nucleotide polymorphisms in miRNA and breast cancer risk: an updated review
Biological Research (2021)
-
Identification of miRNA signatures and their therapeutic potentials in prostate cancer
Molecular Biology Reports (2021)
-
MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2
Molecular and Cellular Biochemistry (2021)
-
Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
Scientific Reports (2020)